*The Regulatory Intelligence Networking Group (RING) comprises the following individuals: Bertrand Borie, head of regulatory intelligence at Sanofi-Pasteur; Julie D Doel, manager regulatory and policy - Europe at GlaxoSmithKline; Mats Ericson, director regulatory intelligence - Europe at Wyeth; Elisabeth Fournier-Qezari, director regulatory intelligence at Sanofi-Aventis; Katie Harrison, associate director regulatory policy - Europe at Baxter; Angelika Joos, associate director regulatory policy at Merck & Co; Marianne Köhne, from the regulatory intelligence office at Boehringer Ingelheim; Erin O'Boyle, from regulatory intelligence at Amgen; Christine Mayer-Nicolai, senior regulatory intelligence expert at Merck Sereno; Ulrich Müller, regulatory intelligence manager at Bayer Healthcare; Cecilia Potez, associate director regulatory intelligence at AstraZeneca); and Nick Sykes, director regulatory policy and intelligence at Pfizer).
The pharmaceutical industry is one of the most heavily regulated of all industries. As a result, the increasing reliance that companies are placing on regulatory intelligence is not unexpected. While...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?